Nearly a third of all cancers have mutations in the RAS family of genes, including KRAS. In pancreatic cancer, a particularly aggressive and difficult-to-treat disease, almost every tumor is driven by KRAS mutations. But KRAS has been thought to be "undruggable" - researchers cannot identify an effective therapy against it.
Researchers exposed a key interaction with AGO2 that may contribute to why mutations in KRAS lead to cancer. AGO2 plays a role in silencing genes and processing microRNA - so it impacts many genes. The researchers found AGO2 interacted with both mutated and normal KRAS. The link appeared in all 12 of the cell lines tested. The study appears in Cell Reports.
Studies in cell lines and mouse models showed that AGO2 enhanced the cancer-causing ability of KRAS. The higher the level of AGO2, the more cancerous activity, the researchers found. At the same time, KRAS inhibits AGO2's ability to process microRNA. This impacts the downstream oncogenes and tumor suppressor genes controlled by microRNA.
The finding suggests potential to explore interrupting the KRAS-AGO2 interaction as a possible therapy. Additional research is needed. The study authors plan next to try to replicate their cell findings in a mouse model to confirm the interaction. They will also begin to map it in 3D to begin to identify opportunities for potential therapies.
http://www.uofmhealth.org/news/archive/201602/new-clues-common-and-elusive-kras-cancer-gene
Edited
Latest News
Metabolic rewiring promotes…
By newseditor
Posted 18 Apr
A drug to prevent flu-induc…
By newseditor
Posted 18 Apr
New origin of deep brain waves
By newseditor
Posted 17 Apr
Starving cells hijack prote…
By newseditor
Posted 17 Apr
Miniature battery-free epid…
By newseditor
Posted 17 Apr
Other Top Stories
Local activation of sympathetic neurons increase fat degradation
Read more
Resin based compounds for the treatment of epilepsy?
Read more
Fibroblast growth factor 9 is a novel modulator of depression
Read more
Linking adult neurogenesis to stress and anxiety
Read more
Reducing our own pain is also reducing empathy for pain in others
Read more
Protocols
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Modular dual-color BiAD sen…
By newseditor
Posted 31 Mar
Publications
How does the microbiota con…
By newseditor
Posted 18 Apr
The integrated stress respo…
By newseditor
Posted 18 Apr
The immunobiology of herpes…
By newseditor
Posted 17 Apr
Circulating microbiome DNA…
By newseditor
Posted 17 Apr
Spindle oscillations in com…
By newseditor
Posted 17 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar